Federal Food & Drug AdministrationNeuproParkinson's diseaseAnnouncement

Parkinson’s patch approved

9 May, 2007

The FDA approves Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver a drug called rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.

Add your comments below...